Preliminary study on miRNA in prostate cancer

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Prostate cancer is a significant global health concern.
• Identifying reliable biomarkers for early detection and prognosis is crucial.
• MicroRNAs (miRNAs) are increasingly recognized for their roles in cancer development.

Purpose of the Study:

• To screen for differentially expressed miRNAs in prostate cancer and benign prostate hyperplasia tissues.
• To validate the association of these miRNAs with prostate cancer.
• To investigate the functional role of miRNA-222 in prostate cancer cell lines.

Main Methods:

• Collected prostate tissue and blood samples from patients diagnosed with prostate cancer or hyperplasia.
• Utilized miRNA microarray technology to identify differentially expressed miRNAs.
• Validated miRNA expression levels and performed cell-based assays (CCK8, Transwell, flow cytometry) with miRNA-222 mimics in PC3 cells.

Main Results:

• Identified four key miRNAs (miRNA-144, miRNA-222, miRNA-1248, miRNA-3651) with differential expression.
• Observed significantly lower expression of miRNA-222 in prostate cancer tissues compared to hyperplasia tissues.
• Found reduced expression of miRNA-222, miRNA-1248, and miRNA-3651 in blood samples of prostate cancer patients.
• Overexpression of miRNA-222 in PC3 cells reduced proliferation, invasion, and metastasis, while increasing apoptosis.

Conclusions:

• Specific miRNAs, particularly miRNA-222, show altered expression in prostate cancer.
• The expression levels of miRNA-222, miRNA-1248, and miRNA-3651 in blood may serve as potential diagnostic or prognostic markers.
• miRNA-222 plays a role in regulating prostate cancer cell behavior, including proliferation, invasion, and apoptosis.